378 related articles for article (PubMed ID: 17094096)
21. Bone mass density in adults with sickle cell disease.
Sarrai M; Duroseau H; D'Augustine J; Moktan S; Bellevue R
Br J Haematol; 2007 Feb; 136(4):666-72. PubMed ID: 17223909
[TBL] [Abstract][Full Text] [Related]
22. [Infections in Senegalese children and adolescents with sickle cell anemia: epidemiological aspects].
Diagne I; Soares GM; Gueye A; Diagne-Gueye NR; Fall L; N'Diaye O; Camara B; Diouf S; Fall M
Dakar Med; 2000; 45(1):55-8. PubMed ID: 14666792
[TBL] [Abstract][Full Text] [Related]
23. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
24. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey.
Vichinsky EP; Ohene-Frempong K;
Pediatr Hematol Oncol; 2011 Feb; 28(1):37-42. PubMed ID: 20673029
[TBL] [Abstract][Full Text] [Related]
25. Nontransferrin-bound iron in transfused patients with sickle cell disease.
Inati A; Musallam KM; Cappellini MD; Duca L; Taher AT
Int J Lab Hematol; 2011 Apr; 33(2):133-7. PubMed ID: 21382180
[TBL] [Abstract][Full Text] [Related]
26. Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.
Leitch HA; Chase JM; Goodman TA; Ezzat H; Rollins MD; Wong DH; Badawi M; Leger CS; Ramadan KM; Barnett MJ; Foltz LM; Vickars LM
Hematol Oncol; 2010 Mar; 28(1):40-8. PubMed ID: 19557769
[TBL] [Abstract][Full Text] [Related]
27. Clinical and laboratory features of sickle cell disease in The Netherlands.
Aluoch JR; De Geus A; Goudsmit R
Trop Geogr Med; 1988 Jan; 40(1):7-12. PubMed ID: 3381319
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
[TBL] [Abstract][Full Text] [Related]
29. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
30. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
Kourtis AP; Bansil P; Johnson C; Meikle SF; Posner SF; Jamieson DJ
Pediatr Infect Dis J; 2007 May; 26(5):406-10. PubMed ID: 17468650
[TBL] [Abstract][Full Text] [Related]
31. Clinical and economic burden of infused iron chelation therapy in the United States.
Payne KA; Desrosiers MP; Caro JJ; Baladi JF; Lordan N; Proskorovsky I; Ishak K; Rofail D
Transfusion; 2007 Oct; 47(10):1820-9. PubMed ID: 17880607
[TBL] [Abstract][Full Text] [Related]
32. Iron in sickle-cell disease: what have we learned over the years?
Inati A; Khoriaty E; Musallam KM
Pediatr Blood Cancer; 2011 Feb; 56(2):182-90. PubMed ID: 21157888
[TBL] [Abstract][Full Text] [Related]
33. Survival and complications in thalassemia.
Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
[TBL] [Abstract][Full Text] [Related]
34. Quantification of siderophages in bronchoalveolar fluid in transfusional and primary pulmonary hemosiderosis.
Priftis KN; Anthracopoulos MB; Tsakanika C; Tapaki G; Ladis V; Bush A; Nicolaidou P
Pediatr Pulmonol; 2006 Oct; 41(10):972-7. PubMed ID: 16871595
[TBL] [Abstract][Full Text] [Related]
35. Circumstances of death in adult sickle cell disease patients.
Darbari DS; Kple-Faget P; Kwagyan J; Rana S; Gordeuk VR; Castro O
Am J Hematol; 2006 Nov; 81(11):858-63. PubMed ID: 16924640
[TBL] [Abstract][Full Text] [Related]
36. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
Porter JB
Hemoglobin; 2009; 33 Suppl 1():S37-45. PubMed ID: 20001631
[TBL] [Abstract][Full Text] [Related]
38. High nontransferrin bound iron levels and heart disease in thalassemia major.
Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
[TBL] [Abstract][Full Text] [Related]
39. Frequent and prolonged hospitalizations: a risk factor for early mortality in sickle cell disease patients.
Houston-Yu P; Rana SR; Beyer B; Castro O
Am J Hematol; 2003 Mar; 72(3):201-3. PubMed ID: 12605392
[TBL] [Abstract][Full Text] [Related]
40. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
